NIHR | Manchester Biomedical Research Centre

Industry Advisory Board

Recognising that commercial uptake is an important step in enabling the wider reach and clinical impact of Manchester BRC research, we have paired with our partner Health Innovation Manchester to create an industry advisory group that helps guide our commercial strategy.

Chaired By Chris Molloy (CEO, Medicinces Discovery Catapult, BRC Governance Board) the group membership draws from the commercial life sciences, diagnostic and digital sectors and aims to:

  • provide meaningful industry insight on best routes to commercialisation in target markets.
  • act as ‘critical friends’ providing input on the attractiveness, maturity and relevance of our outputs to industry sectors, to help us shift priorities and set realistic strategic objectives.
  • help us identify the right partners to deliver our goals, acting as advocates on a global stage, in order to attract appropriate collaborations.